Navigation Links
2007 InfantSEE(R) Data Magnifies the Need for Early Eye and Vision Screenings for Infants, According to American Optometric Association
Date:10/26/2007

Overall Need for Concern Increases to One in Nine Infants, Especially in

Premature and Minority Babies

ST. LOUIS, Oct. 26 /PRNewswire/ -- Eye assessments from one in nine infants have shown an overall need for concern, according to new data collected by the American Optometric Association (AOA) via 10,000 InfantSEE(R) assessments conducted during 2006 and 2007. The overall need for concern has increased from one in 14 last year and clearly reveals a growing need for early vision examination in infants.

The data also showed that the two groups at greatest risk for abnormal prescription status were those born prematurely and those from ethnic minority backgrounds.

InfantSEE(R), a public health program developed by the AOA in partnership with The Vision Care Institute of Johnson & Johnson Vision Care, Inc., was designed to provide professional eye care for infants nationwide at no cost regardless of family income. The program launched in 2005 with support from former President Jimmy Carter, honorary national chair and spokesman. To date an estimated 125,000 to 150,000 babies have had their eye health and vision assessed.

"These results magnify the growing need for early eye and vision assessments for infants, particularly in premature and minority babies," said Scott Jens, O.D., F.A.A.O. and InfantSEE(R) chairman. "InfantSEE is growing to meet that need, and I encourage all parents to take their babies to any of the more than 7,600 optometrists nationwide who provide InfantSEE assessments to detect the risk for potential eye and vision problems."

According to this year's data the majority of vision problems detected include retinoblastoma (eye cancer), severe hyperopia (farsightedness), myopia (nearsightedness), congenital glaucoma and congenital cataract.

Public health experts agree that visual development is most dramatic between 6 and 12 months of age and that early detection can prevent and help red
'/>"/>

SOURCE American Optometric Association
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Gene linked to early puberty in girls
2. Cancer drugs in development nearly doubled since 1995
3. Nearly all asthma deaths preventable
4. Ductal lavage may detect early breast cancer
5. Doctors advice early anemia tests
6. Heart disease threat starts early in life for Diabetics
7. Early detection of prostate cancer
8. Early detection of heart attack
9. Early puberty linked to nutrition
10. Exercise to Prevent Early Breast Cancer
11. Drug Found To Bring Relief For Individuals With Early Parkinson’

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)... Nov. 4 The United Stat...d in a False Claims Act suit in the Western Distri...ersal Health Services Inc., Keystone Marion LLC an...ustice Department announced today. They did busine...ial facility in Marion, Va., that receives Medicai...
(Date:11/4/2009)...re condition, it might have a wider application, e...Day News) -- A new drug designed to treat patients...der applications, perhaps replacing other anemia t...sk of death, cancer and stroke, experts say. , ...ients who have pure red-cell aplasia, a condition ...
(Date:11/4/2009)... CRL Senior Living Communities Continued G...nd Alzheimer’s/Memory Care , ... Industry innovator CRL Senior Living Communities...or, Waukesha, its newest Alzheimer’s/memory ...ovember 19 from 4 to 7 p.m. , , , , ,The public i...
(Date:11/4/2009)...Y, Calif., Nov. 4 Genomi...ancial results and business progress for the quart...ncreased to $39.5 million in the third quarter of ...ter of 2008. Product revenue from the Onco type ...he third quarter of 2009, an increase of 39 percen...
(Date:11/4/2009)...v. 4 Service Corporation... of deathcare products and services in North Ameri...009. Our unaudited condensed consolidated financi...s release. The table below summarizes our key fin... Three Months Ended Nine Months Ended, ...
Breaking Medicine News(10 mins):Health News:United States Intervenes in False Claims Act Suit Against Virginia Medicaid Providers 2Health News:Will New Anemia Drug Top Current Treatments? 2Health News:Will New Anemia Drug Top Current Treatments? 3Health News:Merrill Hills Manor, New Alzheimer's/Memory Care and Assisted Living Community, Welcomes Public to Grand Opening on November 19 in Waukesha 2Health News:Merrill Hills Manor, New Alzheimer's/Memory Care and Assisted Living Community, Welcomes Public to Grand Opening on November 19 in Waukesha 3Health News:Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress 2Health News:Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress 3Health News:Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress 4Health News:Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress 5Health News:Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress 6Health News:Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress 7Health News:Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress 8Health News:Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress 9Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 2Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 3Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 4Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 5Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 6Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 7Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 8Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 9Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 10Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 11Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 12Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 13Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 14Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 15Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 16Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 17Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 18Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 19Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 20Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 21Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 22Health News:Service Corporation International Announces Third Quarter 2009 Financial Results 23
...rchers at the University of Pennsylvania School of... that translates blood flow into gene expression. ...e embryonic development a transcription factor cal... Cell. Understanding Klf2’s role in blood vessel a...
...rchers from Montana State University(MSU) and thei...or discoveries involving a common parasite that ca.... Their findings about Toxoplasma gondii and toxop...nce published a paper on Dec. 15 and PLoS Pathogen...
...dy has indicated that inflammatory bowel disease i...n pregnancy by almost two times.// Diseases ...pregnant women could result in low birth weight ba... risks. The St. Mary's Hospital team analyz...
... potentially deadly bacterium that could be used a...uman immune system is now better understood, Unive... issue of the Journal of Leukocyte Biology. ... infected rabbits or ingesting contaminated food, ...
...rchers at the University of Texas M. D. Anderson C...gy drug over the span of 40 years reduced the tumo... in improved effect of chemotherapy. The Jou... than just the administration of chemotherapy agen...
...ice President, Dr Choong-Siew Yong, today urged Au...ho will be alone over Christmas.// 'This tim...with friends and family, but for some it spells on...ession for those who are socially isolated. ...
Other Medicine News:Health News:How Blood Flow Dictates Gene Expression 2Health News:New Findings on Toxoplasmosis 2Health News:New Findings on Toxoplasmosis 3Health News:Clues Found On How Deadly Bacterium Gains Foothold 2Health News:Clues Found On How Deadly Bacterium Gains Foothold 3Health News:Anti Allergy Drugs Reduce Tumor Growth 2Health News:Anti Allergy Drugs Reduce Tumor Growth 3
(Date:11/4/2009)...lif., Nov. 4 InterMune, ...submitted an electronic New Drug Application (NDA)...seeking approval to market pirfenidone for the tre...sis (IPF). Pirfenidone has been granted Orphan Dr... has been granted Orphan Drug status in Europe. ,...
(Date:11/4/2009)...O, Nov. 4 VIA Pharmaceut...any focused on the development of compounds for th...e, today announced that Dr. Rebecca Taub, Senior V...ent "VIA-3196, a Liver-directed Thyroid Beta Agoni...stract Oral Session on Novel Biological Mechanisms...
(Date:11/4/2009)...ov. 4 Imagenetix, Inc. (...uance of a new U.S. patent (No. 7,612,111). The pa... Imagenetix,s 1-TDC early stage drug candidate for...se. ,, Commenting on the patent issuance, Mr. W..."The issuance is a significant development relatin...
Breaking Medicine Technology:InterMune Announces Submission of NDA for Pirfenidone for the Treatment of Patients with IPF 2InterMune Announces Submission of NDA for Pirfenidone for the Treatment of Patients with IPF 3InterMune Announces Submission of NDA for Pirfenidone for the Treatment of Patients with IPF 4VIA Pharmaceuticals Featured at American Heart Association Scientific Sessions 2009 2VIA Pharmaceuticals Featured at American Heart Association Scientific Sessions 2009 3VIA Pharmaceuticals Featured at American Heart Association Scientific Sessions 2009 4Imagenetix Announces Issuance of New U.S. Patent for the Prevention and Treatment of Periodontal Disease 2Eli Lilly Children International Launches Teen Campaign to Reduce TB Cases in India 54417 1Eli Lilly Children International Launches Teen Campaign to Reduce TB Cases in India 54417 2Eli Lilly Children International Launches Teen Campaign to Reduce TB Cases in India 54417 3Ventilation After Breathing Tube Removal May Alter Outcomes 54416 1Ventilation After Breathing Tube Removal May Alter Outcomes 54416 2Cancer Deaths Declining Especially Among Young 54413 1Cancer Deaths Declining Especially Among Young 54413 2Cancer Deaths Declining Especially Among Young 54413 3
...esented at the World Muscle Society International ...erapeutics, Inc.,(PTC), a biopharmaceutical compan...cialization of small-molecule drugs targeting,post...ed additional data,from a Phase 2 clinical trial o...phy (DMD) due to a nonsense mutation. The results,...
...e Results of Phase II Study in Previous Nonrespond...ering-Plough,Corporation (NYSE: SGP ) today provi...for boceprevir, its investigational oral hepatitis...oing Phase II study in,treatment-naive (previously... (800 mg TID) in combination with PEGINTRON(TM) (p...
Other Medicine Technology:PTC Therapeutics Announces Additional Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 2PTC Therapeutics Announces Additional Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 3PTC Therapeutics Announces Additional Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 4Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 2Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 3Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 4Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 5Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 6Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 7Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 8Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 9
...scular Mikro-Tip Pressure Catheters; Millar manufa...catheters for simultaneous high fidelity pressure ...suring pressure gradients across a valve, between ...ters are made of Polyurethane material (some inclu...
...eople in the United States dying from Sudden Cardi...commended that AEDs be used as a standard of care ...fe-saving shock during a cardiac arrest, but the C...ilities during and after resuscitation. Plus this ...
Fogarty Thru-Lumen Embolectomy Catheter
AVX Catheter
Medicine Products: